JILL SARANTHUS: Open Payments
NPI 1346352721 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Novo Nordisk Inc | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
| Abbott Laboratories | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Korlym, CAPLYTA, Ozempic, QULIPTA, FREESTYLE LIBRE 3, Heplisav-B, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
